Literature DB >> 28506367

Immunohistochemistry in the Diagnosis of Hepatocellular Carcinoma.

Won-Tak Choi1, Sanjay Kakar2.   

Abstract

Hepatocellular carcinoma (HCC) can be difficult to distinguish from its mimics, including metastatic tumor, benign hepatocellular lesion, and high-grade dysplastic nodule, especially when limited biopsy material is available. Hence, the judicious use of immunohistochemical stains is necessary to establish a correct diagnosis. This article describes advantages and disadvantages of immunohistochemical markers that are most commonly used to distinguish between these lesions. Diagnostic workup of malignant liver mass (HCC and its histologic variants vs metastatic tumor) as well as well-differentiated hepatocellular lesion (well-differentiated HCC vs focal nodular hyperplasia vs hepatocellular adenoma) is also discussed.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Focal nodular hyperplasia; Hepatocellular adenoma; Hepatocellular carcinoma; Immunohistochemistry; Well-differentiated hepatocellular lesion

Mesh:

Substances:

Year:  2017        PMID: 28506367     DOI: 10.1016/j.gtc.2017.01.006

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  7 in total

1.  Hepatic ameliorative role of vitamin B17 against Ehrlich ascites carcinoma-induced liver toxicity.

Authors:  Ehab Tousson; Ezar Hafez; Maha Mohamed Abo Gazia; Siham Bayomi Salem; Thulfiqar Fawwaz Mutar
Journal:  Environ Sci Pollut Res Int       Date:  2020-01-08       Impact factor: 4.223

2.  Rare case of hepatocellular carcinoma metastasis to urinary bladder: A case report.

Authors:  Yohan Kim; Young Seok Kim; Jeong-Ju Yoo; Sang Gyune Kim; Susie Chin; Ahrim Moon
Journal:  World J Clin Cases       Date:  2022-06-06       Impact factor: 1.534

Review 3.  Biliary Atresia: A Complex Hepatobiliary Disease with Variable Gene Involvement, Diagnostic Procedures, and Prognosis.

Authors:  Consolato M Sergi; Susan Gilmour
Journal:  Diagnostics (Basel)       Date:  2022-01-27

Review 4.  Immunocytochemistry of effusions: Processing and commonly used immunomarkers.

Authors:  Vinod B Shidham; Beata Janikowski
Journal:  Cytojournal       Date:  2022-01-31       Impact factor: 2.345

5.  Knockdown of STK39 suppressed cell proliferation, migration, and invasion in hepatocellular carcinoma by repressing the phosphorylation of mitogen-activated protein kinase p38.

Authors:  Jian Chen; Luke Zhou; Jie Yang; Hui Xie; Lin Liu; Youwei Li
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

6.  Serum exosomal long noncoding RNA CRNDE as a prognostic biomarker for hepatocellular carcinoma.

Authors:  Ting Wang; Hengkai Zhu; Min Xiao; Shao Zhou
Journal:  J Clin Lab Anal       Date:  2021-10-06       Impact factor: 2.352

7.  Covalent Chemistry-Mediated Multimarker Purification of Circulating Tumor Cells Enables Noninvasive Detection of Molecular Signatures of Hepatocellular Carcinoma.

Authors:  Na Sun; Yi-Te Lee; Minhyung Kim; Jasmine J Wang; Ceng Zhang; Pai-Chi Teng; Dongping Qi; Ryan Y Zhang; Benjamin V Tran; Yue Tung Lee; Jinglei Ye; Juvelyn Palomique; Nicholas N Nissen; Steven-Huy B Han; Saeed Sadeghi; Richard S Finn; Sammy Saab; Ronald W Busuttil; Edwin M Posadas; Li Liang; Renjun Pei; Ju Dong Yang; Sungyong You; Vatche G Agopian; Hsian-Rong Tseng; Yazhen Zhu
Journal:  Adv Mater Technol       Date:  2021-04-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.